nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DCK—hematologic cancer	0.108	1	CbGaD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Pentostatin—hematologic cancer	0.0864	0.308	CiPCiCtD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Clofarabine—hematologic cancer	0.0864	0.308	CiPCiCtD
Nelarabine—Clofarabine—hematologic cancer	0.0694	0.322	CrCtD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Cytarabine—hematologic cancer	0.0655	0.233	CiPCiCtD
Nelarabine—Fludarabine—hematologic cancer	0.051	0.237	CrCtD
Nelarabine—Cytarabine—hematologic cancer	0.0481	0.223	CrCtD
Nelarabine—Cladribine—hematologic cancer	0.0469	0.218	CrCtD
Nelarabine—ADA—Pentostatin—hematologic cancer	0.0424	0.253	CbGbCtD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—hematologic cancer	0.0422	0.15	CiPCiCtD
Nelarabine—POLA1—Clofarabine—hematologic cancer	0.0252	0.15	CbGbCtD
Nelarabine—POLA1—Fludarabine—hematologic cancer	0.0191	0.114	CbGbCtD
Nelarabine—DCK—Clofarabine—hematologic cancer	0.0155	0.0925	CbGbCtD
Nelarabine—POLA1—Cytarabine—hematologic cancer	0.013	0.0777	CbGbCtD
Nelarabine—POLA1—Cladribine—hematologic cancer	0.0123	0.0734	CbGbCtD
Nelarabine—DCK—Fludarabine—hematologic cancer	0.0118	0.0701	CbGbCtD
Nelarabine—Abacavir—Cladribine—hematologic cancer	0.0117	0.0766	CrCrCtD
Nelarabine—DCK—Cytarabine—hematologic cancer	0.00803	0.0478	CbGbCtD
Nelarabine—POLA1—Gemcitabine—hematologic cancer	0.00793	0.0473	CbGbCtD
Nelarabine—DCK—Cladribine—hematologic cancer	0.00758	0.0452	CbGbCtD
Nelarabine—DCK—Gemcitabine—hematologic cancer	0.00489	0.0291	CbGbCtD
Nelarabine—Ribavirin—Clofarabine—hematologic cancer	0.00442	0.029	CrCrCtD
Nelarabine—Regadenoson—Clofarabine—hematologic cancer	0.00412	0.0271	CrCrCtD
Nelarabine—S-Adenosylmethionine—Clofarabine—hematologic cancer	0.00412	0.0271	CrCrCtD
Nelarabine—Fludarabine—Clofarabine—hematologic cancer	0.00386	0.0254	CrCrCtD
Nelarabine—Adenosine—Pentostatin—hematologic cancer	0.00367	0.0241	CrCrCtD
Nelarabine—Vidarabine—Pentostatin—hematologic cancer	0.00367	0.0241	CrCrCtD
Nelarabine—Cladribine—Pentostatin—hematologic cancer	0.00367	0.0241	CrCrCtD
Nelarabine—Azacitidine—Pentostatin—hematologic cancer	0.00367	0.0241	CrCrCtD
Nelarabine—Adenosine monophosphate—Clofarabine—hematologic cancer	0.00364	0.0239	CrCrCtD
Nelarabine—Adenosine triphosphate—Fludarabine—hematologic cancer	0.0035	0.023	CrCrCtD
Nelarabine—Decitabine—Pentostatin—hematologic cancer	0.0035	0.023	CrCrCtD
Nelarabine—Cytarabine—Clofarabine—hematologic cancer	0.00345	0.0226	CrCrCtD
Nelarabine—Azacitidine—Clofarabine—hematologic cancer	0.00327	0.0215	CrCrCtD
Nelarabine—Vidarabine—Clofarabine—hematologic cancer	0.00327	0.0215	CrCrCtD
Nelarabine—Cladribine—Clofarabine—hematologic cancer	0.00327	0.0215	CrCrCtD
Nelarabine—Adenosine—Clofarabine—hematologic cancer	0.00327	0.0215	CrCrCtD
Nelarabine—Ribavirin—Fludarabine—hematologic cancer	0.00324	0.0213	CrCrCtD
Nelarabine—Decitabine—Clofarabine—hematologic cancer	0.00312	0.0205	CrCrCtD
Nelarabine—Ribavirin—Cytarabine—hematologic cancer	0.00306	0.0201	CrCrCtD
Nelarabine—S-Adenosylmethionine—Fludarabine—hematologic cancer	0.00302	0.0199	CrCrCtD
Nelarabine—Clofarabine—Fludarabine—hematologic cancer	0.00302	0.0199	CrCrCtD
Nelarabine—Regadenoson—Fludarabine—hematologic cancer	0.00302	0.0199	CrCrCtD
Nelarabine—S-Adenosylmethionine—Cytarabine—hematologic cancer	0.00286	0.0188	CrCrCtD
Nelarabine—Regadenoson—Cytarabine—hematologic cancer	0.00286	0.0188	CrCrCtD
Nelarabine—Clofarabine—Cytarabine—hematologic cancer	0.00286	0.0188	CrCrCtD
Nelarabine—Regadenoson—Cladribine—hematologic cancer	0.00278	0.0183	CrCrCtD
Nelarabine—Clofarabine—Cladribine—hematologic cancer	0.00278	0.0183	CrCrCtD
Nelarabine—Fludarabine—Cytarabine—hematologic cancer	0.00268	0.0176	CrCrCtD
Nelarabine—Adenosine monophosphate—Fludarabine—hematologic cancer	0.00267	0.0176	CrCrCtD
Nelarabine—Fludarabine—Cladribine—hematologic cancer	0.00261	0.0171	CrCrCtD
Nelarabine—Cytarabine—Fludarabine—hematologic cancer	0.00253	0.0166	CrCrCtD
Nelarabine—Adenosine monophosphate—Cytarabine—hematologic cancer	0.00252	0.0166	CrCrCtD
Nelarabine—Adenosine monophosphate—Cladribine—hematologic cancer	0.00246	0.0162	CrCrCtD
Nelarabine—Vidarabine—Fludarabine—hematologic cancer	0.0024	0.0158	CrCrCtD
Nelarabine—Adenosine—Fludarabine—hematologic cancer	0.0024	0.0158	CrCrCtD
Nelarabine—Cladribine—Fludarabine—hematologic cancer	0.0024	0.0158	CrCrCtD
Nelarabine—Azacitidine—Fludarabine—hematologic cancer	0.0024	0.0158	CrCrCtD
Nelarabine—Cytarabine—Gemcitabine—hematologic cancer	0.00239	0.0157	CrCrCtD
Nelarabine—Adenosine—Cytarabine—hematologic cancer	0.00227	0.0149	CrCrCtD
Nelarabine—Vidarabine—Cytarabine—hematologic cancer	0.00227	0.0149	CrCrCtD
Nelarabine—Azacitidine—Cytarabine—hematologic cancer	0.00227	0.0149	CrCrCtD
Nelarabine—Azacitidine—Gemcitabine—hematologic cancer	0.00227	0.0149	CrCrCtD
Nelarabine—Adenosine—Cladribine—hematologic cancer	0.00221	0.0145	CrCrCtD
Nelarabine—Azacitidine—Cladribine—hematologic cancer	0.00221	0.0145	CrCrCtD
Nelarabine—Vidarabine—Cladribine—hematologic cancer	0.00221	0.0145	CrCrCtD
Nelarabine—Decitabine—Cytarabine—hematologic cancer	0.00216	0.0142	CrCrCtD
Nelarabine—Decitabine—Gemcitabine—hematologic cancer	0.00216	0.0142	CrCrCtD
Nelarabine—Decitabine—Cladribine—hematologic cancer	0.00211	0.0138	CrCrCtD
Nelarabine—DGUOK—hematopoietic system—hematologic cancer	0.000986	0.0987	CbGeAlD
Nelarabine—DGUOK—blood—hematologic cancer	0.000653	0.0654	CbGeAlD
Nelarabine—DGUOK—bone marrow—hematologic cancer	0.000632	0.0633	CbGeAlD
Nelarabine—POLA1—hematopoietic system—hematologic cancer	0.000608	0.0609	CbGeAlD
Nelarabine—DGUOK—lung—hematologic cancer	0.000572	0.0573	CbGeAlD
Nelarabine—ADA—hematopoietic system—hematologic cancer	0.000564	0.0565	CbGeAlD
Nelarabine—DGUOK—testis—hematologic cancer	0.00054	0.0541	CbGeAlD
Nelarabine—POLA1—blood—hematologic cancer	0.000403	0.0404	CbGeAlD
Nelarabine—DGUOK—lymph node—hematologic cancer	0.000392	0.0392	CbGeAlD
Nelarabine—POLA1—bone marrow—hematologic cancer	0.00039	0.039	CbGeAlD
Nelarabine—DCK—hematopoietic system—hematologic cancer	0.000375	0.0375	CbGeAlD
Nelarabine—ADA—blood—hematologic cancer	0.000374	0.0374	CbGeAlD
Nelarabine—ADA—bone marrow—hematologic cancer	0.000362	0.0362	CbGeAlD
Nelarabine—POLA1—lung—hematologic cancer	0.000353	0.0354	CbGeAlD
Nelarabine—POLA1—testis—hematologic cancer	0.000333	0.0334	CbGeAlD
Nelarabine—ADA—lung—hematologic cancer	0.000328	0.0328	CbGeAlD
Nelarabine—ADA—testis—hematologic cancer	0.000309	0.031	CbGeAlD
Nelarabine—DCK—gonad—hematologic cancer	0.000285	0.0286	CbGeAlD
Nelarabine—DCK—blood—hematologic cancer	0.000248	0.0249	CbGeAlD
Nelarabine—POLA1—lymph node—hematologic cancer	0.000242	0.0242	CbGeAlD
Nelarabine—DCK—bone marrow—hematologic cancer	0.00024	0.0241	CbGeAlD
Nelarabine—ADA—lymph node—hematologic cancer	0.000224	0.0224	CbGeAlD
Nelarabine—DCK—lung—hematologic cancer	0.000218	0.0218	CbGeAlD
Nelarabine—DCK—testis—hematologic cancer	0.000205	0.0206	CbGeAlD
Nelarabine—DCK—lymph node—hematologic cancer	0.000149	0.0149	CbGeAlD
Nelarabine—Azacitidine—DNMT3A—hematologic cancer	0.000118	0.0996	CrCbGaD
Nelarabine—Decitabine—DNMT3A—hematologic cancer	0.000115	0.0972	CrCbGaD
Nelarabine—Azacitidine—CDA—hematologic cancer	0.000105	0.0887	CrCbGaD
Nelarabine—DCK—Topotecan—Irinotecan—hematologic cancer	9.29e-05	0.141	CbGdCrCtD
Nelarabine—Decitabine—DCK—hematologic cancer	9.02e-05	0.0762	CrCbGaD
Nelarabine—POLA1—Vinblastine—Vinorelbine—hematologic cancer	8.75e-05	0.133	CbGdCrCtD
Nelarabine—Abacavir—UGT1A1—hematologic cancer	8.52e-05	0.072	CrCbGaD
Nelarabine—Clofarabine—DCK—hematologic cancer	8.45e-05	0.0714	CrCbGaD
Nelarabine—Fludarabine—DCK—hematologic cancer	8.19e-05	0.0692	CrCbGaD
Nelarabine—POLA1—Vinblastine—Vincristine—hematologic cancer	6.99e-05	0.106	CbGdCrCtD
Nelarabine—DCK—Doxorubicin—Daunorubicin—hematologic cancer	6.28e-05	0.0954	CbGdCrCtD
Nelarabine—DCK—Epirubicin—Daunorubicin—hematologic cancer	6.28e-05	0.0954	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ASNS—hematologic cancer	6.19e-05	0.0523	CrCbGaD
Nelarabine—Cytarabine—CDA—hematologic cancer	5.99e-05	0.0506	CrCbGaD
Nelarabine—Adenosine monophosphate—CREB1—hematologic cancer	5.41e-05	0.0457	CrCbGaD
Nelarabine—DCK—Menadione—Thalidomide—hematologic cancer	5.34e-05	0.0811	CbGdCrCtD
Nelarabine—Cytarabine—DCK—hematologic cancer	5.28e-05	0.0446	CrCbGaD
Nelarabine—Cladribine—DCK—hematologic cancer	4.85e-05	0.041	CrCbGaD
Nelarabine—DCK—Epirubicin—Idarubicin—hematologic cancer	4.76e-05	0.0723	CbGdCrCtD
Nelarabine—DCK—Doxorubicin—Idarubicin—hematologic cancer	4.76e-05	0.0723	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ABL2—hematologic cancer	4.69e-05	0.0396	CrCbGaD
Nelarabine—Adenosine triphosphate—ALK—hematologic cancer	2.84e-05	0.024	CrCbGaD
Nelarabine—Adenosine triphosphate—AKT1—hematologic cancer	2.22e-05	0.0187	CrCbGaD
Nelarabine—Adenosine monophosphate—SRC—hematologic cancer	2.19e-05	0.0185	CrCbGaD
Nelarabine—DCK—Doxorubicin—Epirubicin—hematologic cancer	2.18e-05	0.0332	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ABL1—hematologic cancer	2.09e-05	0.0177	CrCbGaD
Nelarabine—DCK—Epirubicin—Doxorubicin—hematologic cancer	2.02e-05	0.0307	CbGdCrCtD
Nelarabine—Adenosine monophosphate—PDE4B—hematologic cancer	1.95e-05	0.0165	CrCbGaD
Nelarabine—Clofarabine—ABCG2—hematologic cancer	1.91e-05	0.0161	CrCbGaD
Nelarabine—Cytarabine—SLC22A1—hematologic cancer	1.7e-05	0.0144	CrCbGaD
Nelarabine—Cladribine—SLC22A1—hematologic cancer	1.57e-05	0.0132	CrCbGaD
Nelarabine—ADA—Metabolism—HDC—hematologic cancer	1.25e-05	0.000606	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HSP90AA1—hematologic cancer	1.25e-05	0.000606	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—EP300—hematologic cancer	1.24e-05	0.000603	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CREB1—hematologic cancer	1.23e-05	0.000599	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	1.23e-05	0.000597	CbGpPWpGaD
Nelarabine—DCK—Metabolism—B3GAT1—hematologic cancer	1.22e-05	0.00059	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ASNS—hematologic cancer	1.22e-05	0.00059	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	1.21e-05	0.000589	CbGpPWpGaD
Nelarabine—POLA1—S Phase—RB1—hematologic cancer	1.2e-05	0.000581	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	1.2e-05	0.000581	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—SMC1A—hematologic cancer	1.18e-05	0.000573	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	1.18e-05	0.000571	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	1.17e-05	0.000569	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—H3F3A—hematologic cancer	1.16e-05	0.000562	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—FOXM1—hematologic cancer	1.15e-05	0.00056	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—H3F3B—hematologic cancer	1.15e-05	0.00056	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HDC—hematologic cancer	1.15e-05	0.000559	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CDA—hematologic cancer	1.14e-05	0.000554	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	1.14e-05	0.000554	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—CDKN1B—hematologic cancer	1.14e-05	0.000552	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	1.13e-05	0.000551	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—STAG2—hematologic cancer	1.13e-05	0.000547	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—HRAS—hematologic cancer	1.13e-05	0.000546	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—RB1—hematologic cancer	1.11e-05	0.000539	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTP1—hematologic cancer	1.11e-05	0.000538	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	1.1e-05	0.000534	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PC—hematologic cancer	1.1e-05	0.000534	CbGpPWpGaD
Nelarabine—Cladribine—ABCG2—hematologic cancer	1.09e-05	0.00925	CrCbGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND3—hematologic cancer	1.09e-05	0.00053	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—MYC—hematologic cancer	1.08e-05	0.000526	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDKN1B—hematologic cancer	1.07e-05	0.000517	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GBA—hematologic cancer	1.06e-05	0.000515	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC35B2—hematologic cancer	1.06e-05	0.000515	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	1.06e-05	0.000512	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CDA—hematologic cancer	1.05e-05	0.000512	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—CDKN1A—hematologic cancer	1.05e-05	0.000509	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCB1—hematologic cancer	1.05e-05	0.000509	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—NUP98—hematologic cancer	1.04e-05	0.000504	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—FOXM1—hematologic cancer	1.03e-05	0.000501	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—H3F3B—hematologic cancer	1.03e-05	0.000501	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1B—hematologic cancer	1.03e-05	0.000498	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.02e-05	0.000497	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTM1—hematologic cancer	1.02e-05	0.000494	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NCOR1—hematologic cancer	1.02e-05	0.000494	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PC—hematologic cancer	1.01e-05	0.000493	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—NUP214—hematologic cancer	1e-05	0.000486	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—NPM1—hematologic cancer	9.93e-06	0.000482	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDKN1A—hematologic cancer	9.84e-06	0.000478	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	9.83e-06	0.000477	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC35B2—hematologic cancer	9.8e-06	0.000476	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GBA—hematologic cancer	9.8e-06	0.000476	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	9.77e-06	0.000474	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND3—hematologic cancer	9.75e-06	0.000473	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	9.72e-06	0.000472	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTAP—hematologic cancer	9.71e-06	0.000471	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	9.68e-06	0.00047	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Betamethasone—hematologic cancer	9.65e-06	0.0147	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Dexamethasone—hematologic cancer	9.65e-06	0.0147	CbGdCrCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	9.64e-06	0.000468	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1A—hematologic cancer	9.47e-06	0.00046	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Triamcinolone—hematologic cancer	9.43e-06	0.0143	CbGdCrCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	9.41e-06	0.000457	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	9.41e-06	0.000457	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	9.41e-06	0.000457	CbGpPWpGaD
Nelarabine—DCK—Diflorasone—Betamethasone—hematologic cancer	9.36e-06	0.0142	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Dexamethasone—hematologic cancer	9.36e-06	0.0142	CbGdCrCtD
Nelarabine—POLA1—S Phase—CDKN1B—hematologic cancer	9.32e-06	0.000452	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—NUP98—hematologic cancer	9.29e-06	0.000451	CbGpPWpGaD
Nelarabine—DCK—Diflorasone—Triamcinolone—hematologic cancer	9.15e-06	0.0139	CbGdCrCtD
Nelarabine—DGUOK—Metabolism—MTHFR—hematologic cancer	9e-06	0.000437	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTAP—hematologic cancer	8.96e-06	0.000435	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—NUP214—hematologic cancer	8.95e-06	0.000435	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Prednisone—hematologic cancer	8.95e-06	0.0136	CbGdCrCtD
Nelarabine—POLA1—S Phase—CCND1—hematologic cancer	8.89e-06	0.000432	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—JUN—hematologic cancer	8.87e-06	0.00043	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—SMC1A—hematologic cancer	8.83e-06	0.000429	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—TOP2A—hematologic cancer	8.74e-06	0.000424	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Prednisolone—hematologic cancer	8.73e-06	0.0133	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Prednisone—hematologic cancer	8.68e-06	0.0132	CbGdCrCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	8.68e-06	0.000421	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FHL2—hematologic cancer	8.66e-06	0.00042	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—H3F3A—hematologic cancer	8.66e-06	0.00042	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	8.65e-06	0.00042	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CDKN1A—hematologic cancer	8.6e-06	0.000418	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PTEN—hematologic cancer	8.58e-06	0.000416	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	8.49e-06	0.000412	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AGRN—hematologic cancer	8.49e-06	0.000412	CbGpPWpGaD
Nelarabine—DCK—Diflorasone—Prednisolone—hematologic cancer	8.47e-06	0.0129	CbGdCrCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	8.45e-06	0.00041	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—MAPK8—hematologic cancer	8.39e-06	0.000407	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—hematologic cancer	8.25e-06	0.000401	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MLH1—hematologic cancer	8.25e-06	0.0004	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—EP300—hematologic cancer	8.18e-06	0.000397	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK6—hematologic cancer	8.13e-06	0.000395	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	8.07e-06	0.000392	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMMR—hematologic cancer	8.05e-06	0.000391	CbGpPWpGaD
Nelarabine—ADA—Metabolism—IDH2—hematologic cancer	8.05e-06	0.000391	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FHL2—hematologic cancer	7.99e-06	0.000388	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	7.98e-06	0.000388	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—SMC1A—hematologic cancer	7.9e-06	0.000383	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—MYC—hematologic cancer	7.86e-06	0.000381	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AGRN—hematologic cancer	7.83e-06	0.00038	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TOP2A—hematologic cancer	7.82e-06	0.000379	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—H3F3A—hematologic cancer	7.74e-06	0.000376	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	7.73e-06	0.000375	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	7.67e-06	0.000372	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ARNTL—hematologic cancer	7.57e-06	0.000367	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CG—hematologic cancer	7.56e-06	0.000367	CbGpPWpGaD
Nelarabine—DCK—Metabolism—IDH2—hematologic cancer	7.43e-06	0.000361	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMMR—hematologic cancer	7.43e-06	0.000361	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACP5—hematologic cancer	7.36e-06	0.000357	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA9—hematologic cancer	7.36e-06	0.000357	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	7.29e-06	0.000354	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	7.29e-06	0.000354	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDK6—hematologic cancer	7.27e-06	0.000353	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NCOR2—hematologic cancer	7.26e-06	0.000353	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—hematologic cancer	7.23e-06	0.000351	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	7.18e-06	0.000348	CbGpPWpGaD
Nelarabine—POLA1—S Phase—MYC—hematologic cancer	7.13e-06	0.000346	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CREBBP—hematologic cancer	7.01e-06	0.00034	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND2—hematologic cancer	6.99e-06	0.000339	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ARNTL—hematologic cancer	6.98e-06	0.000339	CbGpPWpGaD
Nelarabine—ADA—Metabolism—IDH1—hematologic cancer	6.92e-06	0.000336	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TXN—hematologic cancer	6.84e-06	0.000332	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTO1—hematologic cancer	6.84e-06	0.000332	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCC3—hematologic cancer	6.84e-06	0.000332	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA9—hematologic cancer	6.79e-06	0.00033	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACP5—hematologic cancer	6.79e-06	0.00033	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOR2—hematologic cancer	6.7e-06	0.000325	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SPHK1—hematologic cancer	6.7e-06	0.000325	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CD—hematologic cancer	6.65e-06	0.000323	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—CDK2—hematologic cancer	6.63e-06	0.000322	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—hematologic cancer	6.62e-06	0.000321	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALB—hematologic cancer	6.56e-06	0.000318	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	6.55e-06	0.000318	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—HSP90AA1—hematologic cancer	6.52e-06	0.000316	CbGpPWpGaD
Nelarabine—ADA—Metabolism—UGT1A1—hematologic cancer	6.43e-06	0.000312	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	6.42e-06	0.000312	CbGpPWpGaD
Nelarabine—DCK—Metabolism—IDH1—hematologic cancer	6.39e-06	0.00031	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCC3—hematologic cancer	6.31e-06	0.000307	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTO1—hematologic cancer	6.31e-06	0.000307	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TXN—hematologic cancer	6.31e-06	0.000307	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3R1—hematologic cancer	6.28e-06	0.000305	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	6.27e-06	0.000304	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC22A1—hematologic cancer	6.26e-06	0.000304	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CRABP1—hematologic cancer	6.26e-06	0.000304	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	6.25e-06	0.000304	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND2—hematologic cancer	6.25e-06	0.000303	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	6.24e-06	0.000303	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SPHK1—hematologic cancer	6.18e-06	0.0003	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALOX5—hematologic cancer	6.1e-06	0.000296	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	6.05e-06	0.000294	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	6.04e-06	0.000293	CbGpPWpGaD
Nelarabine—DCK—Metabolism—UGT1A1—hematologic cancer	5.94e-06	0.000288	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NUP98—hematologic cancer	5.91e-06	0.000287	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	5.9e-06	0.000287	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—hematologic cancer	5.85e-06	0.000284	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CB—hematologic cancer	5.79e-06	0.000281	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC22A1—hematologic cancer	5.78e-06	0.00028	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CRABP1—hematologic cancer	5.78e-06	0.00028	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.76e-06	0.000279	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADCY7—hematologic cancer	5.73e-06	0.000278	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NCOA3—hematologic cancer	5.73e-06	0.000278	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NUP214—hematologic cancer	5.69e-06	0.000276	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALOX5—hematologic cancer	5.63e-06	0.000273	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2B—hematologic cancer	5.6e-06	0.000272	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.6e-06	0.000272	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTR—hematologic cancer	5.58e-06	0.000271	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCG2—hematologic cancer	5.58e-06	0.000271	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ENO2—hematologic cancer	5.47e-06	0.000266	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.45e-06	0.000265	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NUP98—hematologic cancer	5.45e-06	0.000265	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—RB1—hematologic cancer	5.45e-06	0.000265	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—BIRC5—hematologic cancer	5.41e-06	0.000262	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—hematologic cancer	5.36e-06	0.00026	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTT1—hematologic cancer	5.31e-06	0.000258	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ADCY7—hematologic cancer	5.29e-06	0.000257	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOA3—hematologic cancer	5.29e-06	0.000257	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NUP214—hematologic cancer	5.25e-06	0.000255	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SDC1—hematologic cancer	5.19e-06	0.000252	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.16e-06	0.00025	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG2—hematologic cancer	5.15e-06	0.00025	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTR—hematologic cancer	5.15e-06	0.00025	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ENO2—hematologic cancer	5.05e-06	0.000245	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	5.02e-06	0.000243	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTEN—hematologic cancer	5.01e-06	0.000243	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	5e-06	0.000243	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK2—hematologic cancer	4.96e-06	0.000241	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTT1—hematologic cancer	4.9e-06	0.000238	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BIRC5—hematologic cancer	4.83e-06	0.000235	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SDC1—hematologic cancer	4.79e-06	0.000232	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—EP300—hematologic cancer	4.77e-06	0.000232	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK4—hematologic cancer	4.69e-06	0.000228	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TERT—hematologic cancer	4.68e-06	0.000227	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.67e-06	0.000227	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.63e-06	0.000225	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDK2—hematologic cancer	4.43e-06	0.000215	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CD44—hematologic cancer	4.41e-06	0.000214	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NQO1—hematologic cancer	4.41e-06	0.000214	CbGpPWpGaD
Nelarabine—Nausea—Thalidomide—hematologic cancer	4.27e-06	9.8e-05	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.26e-06	0.000207	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Doxorubicin—hematologic cancer	4.25e-06	9.77e-05	CcSEcCtD
Nelarabine—Dizziness—Irinotecan—hematologic cancer	4.24e-06	9.74e-05	CcSEcCtD
Nelarabine—Stomatitis—Doxorubicin—hematologic cancer	4.23e-06	9.71e-05	CcSEcCtD
Nelarabine—Body temperature increased—Etoposide—hematologic cancer	4.22e-06	9.69e-05	CcSEcCtD
Nelarabine—Abdominal pain—Etoposide—hematologic cancer	4.22e-06	9.69e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—ATM—hematologic cancer	4.21e-06	0.000204	CbGpPWpGaD
Nelarabine—Eye disorder—Methotrexate—hematologic cancer	4.2e-06	9.66e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CDK4—hematologic cancer	4.19e-06	0.000203	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Epirubicin—hematologic cancer	4.19e-06	9.62e-05	CcSEcCtD
Nelarabine—Vomiting—Vincristine—hematologic cancer	4.19e-06	9.62e-05	CcSEcCtD
Nelarabine—Anorexia—Dexamethasone—hematologic cancer	4.18e-06	9.61e-05	CcSEcCtD
Nelarabine—Anorexia—Betamethasone—hematologic cancer	4.18e-06	9.61e-05	CcSEcCtD
Nelarabine—Asthenia—Cisplatin—hematologic cancer	4.18e-06	9.6e-05	CcSEcCtD
Nelarabine—Cardiac disorder—Methotrexate—hematologic cancer	4.17e-06	9.59e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—CYCS—hematologic cancer	4.17e-06	0.000203	CbGpPWpGaD
Nelarabine—Fatigue—Triamcinolone—hematologic cancer	4.17e-06	9.58e-05	CcSEcCtD
Nelarabine—Urinary tract disorder—Epirubicin—hematologic cancer	4.16e-06	9.55e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—HSP90AA1—hematologic cancer	4.15e-06	0.000201	CbGpPWpGaD
Nelarabine—Oedema peripheral—Epirubicin—hematologic cancer	4.14e-06	9.52e-05	CcSEcCtD
Nelarabine—Pain—Triamcinolone—hematologic cancer	4.14e-06	9.5e-05	CcSEcCtD
Nelarabine—Connective tissue disorder—Epirubicin—hematologic cancer	4.13e-06	9.5e-05	CcSEcCtD
Nelarabine—Urethral disorder—Epirubicin—hematologic cancer	4.12e-06	9.48e-05	CcSEcCtD
Nelarabine—Headache—Vincristine—hematologic cancer	4.12e-06	9.48e-05	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.12e-06	0.0002	CbGpPWpGaD
Nelarabine—Loss of consciousness—Prednisone—hematologic cancer	4.12e-06	9.46e-05	CcSEcCtD
Nelarabine—Hepatobiliary disease—Doxorubicin—hematologic cancer	4.1e-06	9.42e-05	CcSEcCtD
Nelarabine—Hypotension—Betamethasone—hematologic cancer	4.1e-06	9.42e-05	CcSEcCtD
Nelarabine—Hypotension—Dexamethasone—hematologic cancer	4.1e-06	9.42e-05	CcSEcCtD
Nelarabine—Nausea—Carmustine—hematologic cancer	4.1e-06	9.41e-05	CcSEcCtD
Nelarabine—Epistaxis—Doxorubicin—hematologic cancer	4.09e-06	9.4e-05	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—hematologic cancer	4.08e-06	9.37e-05	CcSEcCtD
Nelarabine—Vomiting—Irinotecan—hematologic cancer	4.08e-06	9.37e-05	CcSEcCtD
Nelarabine—Vomiting—Mitoxantrone—hematologic cancer	4.08e-06	9.37e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—RB1—hematologic cancer	4.08e-06	0.000198	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CD44—hematologic cancer	4.07e-06	0.000198	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NQO1—hematologic cancer	4.07e-06	0.000198	CbGpPWpGaD
Nelarabine—Sinusitis—Doxorubicin—hematologic cancer	4.07e-06	9.35e-05	CcSEcCtD
Nelarabine—Nausea—Alitretinoin—hematologic cancer	4.06e-06	9.33e-05	CcSEcCtD
Nelarabine—Convulsion—Prednisone—hematologic cancer	4.06e-06	9.32e-05	CcSEcCtD
Nelarabine—Mediastinal disorder—Methotrexate—hematologic cancer	4.05e-06	9.31e-05	CcSEcCtD
Nelarabine—Chills—Methotrexate—hematologic cancer	4.03e-06	9.27e-05	CcSEcCtD
Nelarabine—Headache—Irinotecan—hematologic cancer	4.02e-06	9.23e-05	CcSEcCtD
Nelarabine—Headache—Mitoxantrone—hematologic cancer	4.02e-06	9.23e-05	CcSEcCtD
Nelarabine—Nausea—Ifosfamide—hematologic cancer	4.01e-06	9.22e-05	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4e-06	9.19e-05	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4e-06	9.19e-05	CcSEcCtD
Nelarabine—Myalgia—Prednisone—hematologic cancer	3.99e-06	9.16e-05	CcSEcCtD
Nelarabine—Arthralgia—Prednisone—hematologic cancer	3.99e-06	9.16e-05	CcSEcCtD
Nelarabine—Feeling abnormal—Triamcinolone—hematologic cancer	3.99e-06	9.16e-05	CcSEcCtD
Nelarabine—Diarrhoea—Cisplatin—hematologic cancer	3.98e-06	9.15e-05	CcSEcCtD
Nelarabine—Vomiting—Gemcitabine—hematologic cancer	3.97e-06	9.12e-05	CcSEcCtD
Nelarabine—Insomnia—Dexamethasone—hematologic cancer	3.97e-06	9.12e-05	CcSEcCtD
Nelarabine—Insomnia—Betamethasone—hematologic cancer	3.97e-06	9.12e-05	CcSEcCtD
Nelarabine—Paraesthesia—Betamethasone—hematologic cancer	3.94e-06	9.06e-05	CcSEcCtD
Nelarabine—Paraesthesia—Dexamethasone—hematologic cancer	3.94e-06	9.06e-05	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—hematologic cancer	3.94e-06	9.05e-05	CcSEcCtD
Nelarabine—Eye disorder—Epirubicin—hematologic cancer	3.93e-06	9.04e-05	CcSEcCtD
Nelarabine—Malnutrition—Methotrexate—hematologic cancer	3.91e-06	8.99e-05	CcSEcCtD
Nelarabine—Headache—Gemcitabine—hematologic cancer	3.91e-06	8.99e-05	CcSEcCtD
Nelarabine—Nausea—Vincristine—hematologic cancer	3.91e-06	8.99e-05	CcSEcCtD
Nelarabine—Cardiac disorder—Epirubicin—hematologic cancer	3.9e-06	8.97e-05	CcSEcCtD
Nelarabine—Hypoaesthesia—Doxorubicin—hematologic cancer	3.87e-06	8.9e-05	CcSEcCtD
Nelarabine—Adenosine triphosphate—ABCB1—hematologic cancer	3.87e-06	0.00327	CrCbGaD
Nelarabine—DCK—Metabolism—CYCS—hematologic cancer	3.85e-06	0.000187	CbGpPWpGaD
Nelarabine—Urinary tract disorder—Doxorubicin—hematologic cancer	3.84e-06	8.83e-05	CcSEcCtD
Nelarabine—Oedema peripheral—Doxorubicin—hematologic cancer	3.84e-06	8.81e-05	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—hematologic cancer	3.83e-06	8.81e-05	CcSEcCtD
Nelarabine—Asthenia—Etoposide—hematologic cancer	3.83e-06	8.79e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—HSP90AA1—hematologic cancer	3.83e-06	0.000186	CbGpPWpGaD
Nelarabine—Connective tissue disorder—Doxorubicin—hematologic cancer	3.83e-06	8.79e-05	CcSEcCtD
Nelarabine—Body temperature increased—Triamcinolone—hematologic cancer	3.82e-06	8.79e-05	CcSEcCtD
Nelarabine—Oedema—Prednisone—hematologic cancer	3.82e-06	8.78e-05	CcSEcCtD
Nelarabine—Angiopathy—Epirubicin—hematologic cancer	3.82e-06	8.77e-05	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—hematologic cancer	3.82e-06	8.77e-05	CcSEcCtD
Nelarabine—Decreased appetite—Betamethasone—hematologic cancer	3.82e-06	8.77e-05	CcSEcCtD
Nelarabine—Decreased appetite—Dexamethasone—hematologic cancer	3.82e-06	8.77e-05	CcSEcCtD
Nelarabine—Nausea—Mitoxantrone—hematologic cancer	3.81e-06	8.75e-05	CcSEcCtD
Nelarabine—Nausea—Irinotecan—hematologic cancer	3.81e-06	8.75e-05	CcSEcCtD
Nelarabine—Infection—Prednisone—hematologic cancer	3.8e-06	8.73e-05	CcSEcCtD
Nelarabine—Mediastinal disorder—Epirubicin—hematologic cancer	3.79e-06	8.71e-05	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.79e-06	8.71e-05	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.79e-06	8.71e-05	CcSEcCtD
Nelarabine—Back pain—Methotrexate—hematologic cancer	3.79e-06	8.7e-05	CcSEcCtD
Nelarabine—Fatigue—Dexamethasone—hematologic cancer	3.78e-06	8.7e-05	CcSEcCtD
Nelarabine—Fatigue—Betamethasone—hematologic cancer	3.78e-06	8.7e-05	CcSEcCtD
Nelarabine—Chills—Epirubicin—hematologic cancer	3.78e-06	8.68e-05	CcSEcCtD
Nelarabine—Pain—Betamethasone—hematologic cancer	3.75e-06	8.62e-05	CcSEcCtD
Nelarabine—Pain—Dexamethasone—hematologic cancer	3.75e-06	8.62e-05	CcSEcCtD
Nelarabine—Nervous system disorder—Prednisone—hematologic cancer	3.75e-06	8.61e-05	CcSEcCtD
Nelarabine—Nausea—Gemcitabine—hematologic cancer	3.71e-06	8.52e-05	CcSEcCtD
Nelarabine—Vomiting—Cisplatin—hematologic cancer	3.7e-06	8.5e-05	CcSEcCtD
Nelarabine—Vision blurred—Methotrexate—hematologic cancer	3.69e-06	8.48e-05	CcSEcCtD
Nelarabine—Mental disorder—Epirubicin—hematologic cancer	3.69e-06	8.47e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTP1—hematologic cancer	3.68e-06	0.000179	CbGpPWpGaD
Nelarabine—Malnutrition—Epirubicin—hematologic cancer	3.66e-06	8.42e-05	CcSEcCtD
Nelarabine—Diarrhoea—Etoposide—hematologic cancer	3.65e-06	8.38e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—RB1—hematologic cancer	3.64e-06	0.000177	CbGpPWpGaD
Nelarabine—Anorexia—Prednisone—hematologic cancer	3.64e-06	8.37e-05	CcSEcCtD
Nelarabine—Eye disorder—Doxorubicin—hematologic cancer	3.64e-06	8.36e-05	CcSEcCtD
Nelarabine—Anaemia—Methotrexate—hematologic cancer	3.62e-06	8.31e-05	CcSEcCtD
Nelarabine—Feeling abnormal—Betamethasone—hematologic cancer	3.62e-06	8.31e-05	CcSEcCtD
Nelarabine—Feeling abnormal—Dexamethasone—hematologic cancer	3.62e-06	8.31e-05	CcSEcCtD
Nelarabine—Cardiac disorder—Doxorubicin—hematologic cancer	3.61e-06	8.3e-05	CcSEcCtD
Nelarabine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.59e-06	8.25e-05	CcSEcCtD
Nelarabine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.59e-06	8.25e-05	CcSEcCtD
Nelarabine—Dysgeusia—Epirubicin—hematologic cancer	3.59e-06	8.24e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	3.58e-06	0.000174	CbGpPWpGaD
Nelarabine—Back pain—Epirubicin—hematologic cancer	3.54e-06	8.14e-05	CcSEcCtD
Nelarabine—Angiopathy—Doxorubicin—hematologic cancer	3.53e-06	8.12e-05	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CA—hematologic cancer	3.53e-06	0.000171	CbGpPWpGaD
Nelarabine—Dizziness—Etoposide—hematologic cancer	3.53e-06	8.1e-05	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—hematologic cancer	3.51e-06	8.06e-05	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—hematologic cancer	3.5e-06	8.05e-05	CcSEcCtD
Nelarabine—Chills—Doxorubicin—hematologic cancer	3.49e-06	8.03e-05	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.48e-06	8e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—ABCB1—hematologic cancer	3.48e-06	0.000169	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.48e-06	0.000169	CbGpPWpGaD
Nelarabine—Dizziness—Prednisolone—hematologic cancer	3.48e-06	7.99e-05	CcSEcCtD
Nelarabine—Asthenia—Triamcinolone—hematologic cancer	3.47e-06	7.97e-05	CcSEcCtD
Nelarabine—Body temperature increased—Dexamethasone—hematologic cancer	3.47e-06	7.97e-05	CcSEcCtD
Nelarabine—Abdominal pain—Betamethasone—hematologic cancer	3.47e-06	7.97e-05	CcSEcCtD
Nelarabine—Body temperature increased—Betamethasone—hematologic cancer	3.47e-06	7.97e-05	CcSEcCtD
Nelarabine—Abdominal pain—Dexamethasone—hematologic cancer	3.47e-06	7.97e-05	CcSEcCtD
Nelarabine—Nausea—Cisplatin—hematologic cancer	3.46e-06	7.95e-05	CcSEcCtD
Nelarabine—Insomnia—Prednisone—hematologic cancer	3.46e-06	7.94e-05	CcSEcCtD
Nelarabine—Vision blurred—Epirubicin—hematologic cancer	3.45e-06	7.93e-05	CcSEcCtD
Nelarabine—Paraesthesia—Prednisone—hematologic cancer	3.43e-06	7.89e-05	CcSEcCtD
Nelarabine—Cough—Methotrexate—hematologic cancer	3.42e-06	7.85e-05	CcSEcCtD
Nelarabine—Mental disorder—Doxorubicin—hematologic cancer	3.41e-06	7.84e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTP1—hematologic cancer	3.39e-06	0.000165	CbGpPWpGaD
Nelarabine—Convulsion—Methotrexate—hematologic cancer	3.39e-06	7.79e-05	CcSEcCtD
Nelarabine—Vomiting—Etoposide—hematologic cancer	3.39e-06	7.79e-05	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—hematologic cancer	3.39e-06	7.79e-05	CcSEcCtD
Nelarabine—Anaemia—Epirubicin—hematologic cancer	3.39e-06	7.78e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—NCOR1—hematologic cancer	3.38e-06	0.000164	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM1—hematologic cancer	3.38e-06	0.000164	CbGpPWpGaD
Nelarabine—Headache—Etoposide—hematologic cancer	3.34e-06	7.68e-05	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—hematologic cancer	3.34e-06	0.000162	CbGpPWpGaD
Nelarabine—Chest pain—Methotrexate—hematologic cancer	3.33e-06	7.66e-05	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—hematologic cancer	3.33e-06	7.66e-05	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—hematologic cancer	3.33e-06	7.66e-05	CcSEcCtD
Nelarabine—Decreased appetite—Prednisone—hematologic cancer	3.32e-06	7.63e-05	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—hematologic cancer	3.32e-06	7.63e-05	CcSEcCtD
Nelarabine—Fatigue—Prednisone—hematologic cancer	3.3e-06	7.57e-05	CcSEcCtD
Nelarabine—Headache—Prednisolone—hematologic cancer	3.3e-06	7.57e-05	CcSEcCtD
Nelarabine—Leukopenia—Epirubicin—hematologic cancer	3.28e-06	7.53e-05	CcSEcCtD
Nelarabine—Back pain—Doxorubicin—hematologic cancer	3.28e-06	7.53e-05	CcSEcCtD
Nelarabine—Constipation—Prednisone—hematologic cancer	3.27e-06	7.51e-05	CcSEcCtD
Nelarabine—Confusional state—Methotrexate—hematologic cancer	3.22e-06	7.4e-05	CcSEcCtD
Nelarabine—Loss of consciousness—Epirubicin—hematologic cancer	3.22e-06	7.4e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—ABCB1—hematologic cancer	3.21e-06	0.000156	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—hematologic cancer	3.2e-06	0.000156	CbGpPWpGaD
Nelarabine—Dizziness—Triamcinolone—hematologic cancer	3.2e-06	7.35e-05	CcSEcCtD
Nelarabine—Cough—Epirubicin—hematologic cancer	3.2e-06	7.34e-05	CcSEcCtD
Nelarabine—Vision blurred—Doxorubicin—hematologic cancer	3.19e-06	7.34e-05	CcSEcCtD
Nelarabine—Convulsion—Epirubicin—hematologic cancer	3.17e-06	7.29e-05	CcSEcCtD
Nelarabine—Infection—Methotrexate—hematologic cancer	3.17e-06	7.29e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	3.17e-06	0.000154	CbGpPWpGaD
Nelarabine—Nausea—Etoposide—hematologic cancer	3.17e-06	7.28e-05	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisone—hematologic cancer	3.15e-06	7.24e-05	CcSEcCtD
Nelarabine—Asthenia—Dexamethasone—hematologic cancer	3.15e-06	7.24e-05	CcSEcCtD
Nelarabine—Asthenia—Betamethasone—hematologic cancer	3.15e-06	7.24e-05	CcSEcCtD
Nelarabine—Nervous system disorder—Methotrexate—hematologic cancer	3.13e-06	7.2e-05	CcSEcCtD
Nelarabine—Anaemia—Doxorubicin—hematologic cancer	3.13e-06	7.2e-05	CcSEcCtD
Nelarabine—Thrombocytopenia—Methotrexate—hematologic cancer	3.13e-06	7.19e-05	CcSEcCtD
Nelarabine—Gastrointestinal pain—Prednisone—hematologic cancer	3.13e-06	7.18e-05	CcSEcCtD
Nelarabine—Nausea—Prednisolone—hematologic cancer	3.12e-06	7.18e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTM1—hematologic cancer	3.12e-06	0.000151	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOR1—hematologic cancer	3.12e-06	0.000151	CbGpPWpGaD
Nelarabine—Myalgia—Epirubicin—hematologic cancer	3.12e-06	7.17e-05	CcSEcCtD
Nelarabine—Arthralgia—Epirubicin—hematologic cancer	3.12e-06	7.17e-05	CcSEcCtD
Nelarabine—Chest pain—Epirubicin—hematologic cancer	3.12e-06	7.17e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—MDM2—hematologic cancer	3.11e-06	0.000151	CbGpPWpGaD
Nelarabine—Vomiting—Triamcinolone—hematologic cancer	3.08e-06	7.07e-05	CcSEcCtD
Nelarabine—Anorexia—Methotrexate—hematologic cancer	3.04e-06	7e-05	CcSEcCtD
Nelarabine—Leukopenia—Doxorubicin—hematologic cancer	3.03e-06	6.97e-05	CcSEcCtD
Nelarabine—Headache—Triamcinolone—hematologic cancer	3.03e-06	6.96e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—hematologic cancer	3.03e-06	0.000147	CbGpPWpGaD
Nelarabine—Body temperature increased—Prednisone—hematologic cancer	3.02e-06	6.94e-05	CcSEcCtD
Nelarabine—Abdominal pain—Prednisone—hematologic cancer	3.02e-06	6.94e-05	CcSEcCtD
Nelarabine—Confusional state—Epirubicin—hematologic cancer	3.01e-06	6.93e-05	CcSEcCtD
Nelarabine—Diarrhoea—Dexamethasone—hematologic cancer	3e-06	6.9e-05	CcSEcCtD
Nelarabine—Diarrhoea—Betamethasone—hematologic cancer	3e-06	6.9e-05	CcSEcCtD
Nelarabine—Oedema—Epirubicin—hematologic cancer	2.99e-06	6.87e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—MTHFR—hematologic cancer	2.99e-06	0.000145	CbGpPWpGaD
Nelarabine—Hypotension—Methotrexate—hematologic cancer	2.98e-06	6.86e-05	CcSEcCtD
Nelarabine—Loss of consciousness—Doxorubicin—hematologic cancer	2.98e-06	6.84e-05	CcSEcCtD
Nelarabine—Infection—Epirubicin—hematologic cancer	2.97e-06	6.82e-05	CcSEcCtD
Nelarabine—Cough—Doxorubicin—hematologic cancer	2.96e-06	6.8e-05	CcSEcCtD
Nelarabine—Convulsion—Doxorubicin—hematologic cancer	2.94e-06	6.75e-05	CcSEcCtD
Nelarabine—Nervous system disorder—Epirubicin—hematologic cancer	2.93e-06	6.74e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	2.93e-06	0.000142	CbGpPWpGaD
Nelarabine—Thrombocytopenia—Epirubicin—hematologic cancer	2.93e-06	6.73e-05	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.91e-06	6.69e-05	CcSEcCtD
Nelarabine—Dizziness—Dexamethasone—hematologic cancer	2.9e-06	6.67e-05	CcSEcCtD
Nelarabine—Dizziness—Betamethasone—hematologic cancer	2.9e-06	6.67e-05	CcSEcCtD
Nelarabine—Insomnia—Methotrexate—hematologic cancer	2.89e-06	6.64e-05	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—hematologic cancer	2.89e-06	6.63e-05	CcSEcCtD
Nelarabine—Chest pain—Doxorubicin—hematologic cancer	2.89e-06	6.63e-05	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—hematologic cancer	2.89e-06	6.63e-05	CcSEcCtD
Nelarabine—DGUOK—Metabolism—AKT1—hematologic cancer	2.88e-06	0.00014	CbGpPWpGaD
Nelarabine—Nausea—Triamcinolone—hematologic cancer	2.87e-06	6.6e-05	CcSEcCtD
Nelarabine—Paraesthesia—Methotrexate—hematologic cancer	2.87e-06	6.59e-05	CcSEcCtD
Nelarabine—Anorexia—Epirubicin—hematologic cancer	2.85e-06	6.55e-05	CcSEcCtD
Nelarabine—Dyspnoea—Methotrexate—hematologic cancer	2.85e-06	6.54e-05	CcSEcCtD
Nelarabine—Somnolence—Methotrexate—hematologic cancer	2.84e-06	6.53e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CDKN1B—hematologic cancer	2.84e-06	0.000138	CbGpPWpGaD
Nelarabine—Hypotension—Epirubicin—hematologic cancer	2.79e-06	6.42e-05	CcSEcCtD
Nelarabine—Vomiting—Betamethasone—hematologic cancer	2.79e-06	6.41e-05	CcSEcCtD
Nelarabine—Vomiting—Dexamethasone—hematologic cancer	2.79e-06	6.41e-05	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—hematologic cancer	2.79e-06	6.41e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—EP300—hematologic cancer	2.79e-06	0.000135	CbGpPWpGaD
Nelarabine—Decreased appetite—Methotrexate—hematologic cancer	2.78e-06	6.38e-05	CcSEcCtD
Nelarabine—Oedema—Doxorubicin—hematologic cancer	2.77e-06	6.36e-05	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.76e-06	6.34e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—MTHFR—hematologic cancer	2.76e-06	0.000134	CbGpPWpGaD
Nelarabine—Fatigue—Methotrexate—hematologic cancer	2.75e-06	6.33e-05	CcSEcCtD
Nelarabine—Headache—Betamethasone—hematologic cancer	2.75e-06	6.32e-05	CcSEcCtD
Nelarabine—Headache—Dexamethasone—hematologic cancer	2.75e-06	6.32e-05	CcSEcCtD
Nelarabine—Infection—Doxorubicin—hematologic cancer	2.75e-06	6.31e-05	CcSEcCtD
Nelarabine—Asthenia—Prednisone—hematologic cancer	2.74e-06	6.3e-05	CcSEcCtD
Nelarabine—Pain—Methotrexate—hematologic cancer	2.73e-06	6.28e-05	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.72e-06	6.26e-05	CcSEcCtD
Nelarabine—Nervous system disorder—Doxorubicin—hematologic cancer	2.71e-06	6.23e-05	CcSEcCtD
Nelarabine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.71e-06	6.22e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CCND1—hematologic cancer	2.71e-06	0.000131	CbGpPWpGaD
Nelarabine—Insomnia—Epirubicin—hematologic cancer	2.7e-06	6.21e-05	CcSEcCtD
Nelarabine—Paraesthesia—Epirubicin—hematologic cancer	2.68e-06	6.17e-05	CcSEcCtD
Nelarabine—Dyspnoea—Epirubicin—hematologic cancer	2.67e-06	6.12e-05	CcSEcCtD
Nelarabine—Somnolence—Epirubicin—hematologic cancer	2.66e-06	6.11e-05	CcSEcCtD
Nelarabine—Anorexia—Doxorubicin—hematologic cancer	2.64e-06	6.06e-05	CcSEcCtD
Nelarabine—Feeling abnormal—Methotrexate—hematologic cancer	2.63e-06	6.05e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CDKN1A—hematologic cancer	2.62e-06	0.000127	CbGpPWpGaD
Nelarabine—Diarrhoea—Prednisone—hematologic cancer	2.62e-06	6.01e-05	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.61e-06	6e-05	CcSEcCtD
Nelarabine—Nausea—Betamethasone—hematologic cancer	2.61e-06	5.99e-05	CcSEcCtD
Nelarabine—Nausea—Dexamethasone—hematologic cancer	2.61e-06	5.99e-05	CcSEcCtD
Nelarabine—Decreased appetite—Epirubicin—hematologic cancer	2.6e-06	5.97e-05	CcSEcCtD
Nelarabine—Hypotension—Doxorubicin—hematologic cancer	2.58e-06	5.94e-05	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.58e-06	5.93e-05	CcSEcCtD
Nelarabine—Fatigue—Epirubicin—hematologic cancer	2.58e-06	5.92e-05	CcSEcCtD
Nelarabine—Constipation—Epirubicin—hematologic cancer	2.56e-06	5.87e-05	CcSEcCtD
Nelarabine—Pain—Epirubicin—hematologic cancer	2.56e-06	5.87e-05	CcSEcCtD
Nelarabine—Dizziness—Prednisone—hematologic cancer	2.53e-06	5.81e-05	CcSEcCtD
Nelarabine—Abdominal pain—Methotrexate—hematologic cancer	2.53e-06	5.8e-05	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—hematologic cancer	2.53e-06	5.8e-05	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.52e-06	5.79e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—PIK3CG—hematologic cancer	2.51e-06	0.000122	CbGpPWpGaD
Nelarabine—Insomnia—Doxorubicin—hematologic cancer	2.5e-06	5.75e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2.5e-06	0.000121	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—EP300—hematologic cancer	2.49e-06	0.000121	CbGpPWpGaD
Nelarabine—Paraesthesia—Doxorubicin—hematologic cancer	2.48e-06	5.71e-05	CcSEcCtD
Nelarabine—Dyspnoea—Doxorubicin—hematologic cancer	2.47e-06	5.67e-05	CcSEcCtD
Nelarabine—Feeling abnormal—Epirubicin—hematologic cancer	2.46e-06	5.66e-05	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—hematologic cancer	2.46e-06	5.65e-05	CcSEcCtD
Nelarabine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.44e-06	5.62e-05	CcSEcCtD
Nelarabine—Vomiting—Prednisone—hematologic cancer	2.43e-06	5.58e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—hematologic cancer	2.43e-06	0.000118	CbGpPWpGaD
Nelarabine—Decreased appetite—Doxorubicin—hematologic cancer	2.4e-06	5.53e-05	CcSEcCtD
Nelarabine—Headache—Prednisone—hematologic cancer	2.39e-06	5.5e-05	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.39e-06	5.49e-05	CcSEcCtD
Nelarabine—Fatigue—Doxorubicin—hematologic cancer	2.38e-06	5.48e-05	CcSEcCtD
Nelarabine—Pain—Doxorubicin—hematologic cancer	2.37e-06	5.44e-05	CcSEcCtD
Nelarabine—Constipation—Doxorubicin—hematologic cancer	2.37e-06	5.44e-05	CcSEcCtD
Nelarabine—Abdominal pain—Epirubicin—hematologic cancer	2.36e-06	5.43e-05	CcSEcCtD
Nelarabine—Body temperature increased—Epirubicin—hematologic cancer	2.36e-06	5.43e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—CREBBP—hematologic cancer	2.33e-06	0.000113	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CG—hematologic cancer	2.32e-06	0.000112	CbGpPWpGaD
Nelarabine—Asthenia—Methotrexate—hematologic cancer	2.29e-06	5.27e-05	CcSEcCtD
Nelarabine—Feeling abnormal—Doxorubicin—hematologic cancer	2.28e-06	5.24e-05	CcSEcCtD
Nelarabine—Nausea—Prednisone—hematologic cancer	2.27e-06	5.22e-05	CcSEcCtD
Nelarabine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.26e-06	5.2e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—MAPK3—hematologic cancer	2.23e-06	0.000108	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CD—hematologic cancer	2.21e-06	0.000107	CbGpPWpGaD
Nelarabine—Body temperature increased—Doxorubicin—hematologic cancer	2.19e-06	5.02e-05	CcSEcCtD
Nelarabine—Abdominal pain—Doxorubicin—hematologic cancer	2.19e-06	5.02e-05	CcSEcCtD
Nelarabine—Diarrhoea—Methotrexate—hematologic cancer	2.19e-06	5.02e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—ALB—hematologic cancer	2.18e-06	0.000106	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—hematologic cancer	2.17e-06	0.000105	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CREBBP—hematologic cancer	2.15e-06	0.000104	CbGpPWpGaD
Nelarabine—Asthenia—Epirubicin—hematologic cancer	2.14e-06	4.93e-05	CcSEcCtD
Nelarabine—Dizziness—Methotrexate—hematologic cancer	2.11e-06	4.85e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—PIK3R1—hematologic cancer	2.08e-06	0.000101	CbGpPWpGaD
Nelarabine—Diarrhoea—Epirubicin—hematologic cancer	2.05e-06	4.7e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—PIK3CD—hematologic cancer	2.04e-06	9.88e-05	CbGpPWpGaD
Nelarabine—Vomiting—Methotrexate—hematologic cancer	2.03e-06	4.67e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—ALB—hematologic cancer	2.01e-06	9.76e-05	CbGpPWpGaD
Nelarabine—Headache—Methotrexate—hematologic cancer	2e-06	4.6e-05	CcSEcCtD
Nelarabine—Asthenia—Doxorubicin—hematologic cancer	1.98e-06	4.56e-05	CcSEcCtD
Nelarabine—Dizziness—Epirubicin—hematologic cancer	1.98e-06	4.54e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—PIK3CB—hematologic cancer	1.92e-06	9.33e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3R1—hematologic cancer	1.92e-06	9.33e-05	CbGpPWpGaD
Nelarabine—Vomiting—Epirubicin—hematologic cancer	1.9e-06	4.37e-05	CcSEcCtD
Nelarabine—Nausea—Methotrexate—hematologic cancer	1.9e-06	4.36e-05	CcSEcCtD
Nelarabine—Diarrhoea—Doxorubicin—hematologic cancer	1.89e-06	4.35e-05	CcSEcCtD
Nelarabine—Headache—Epirubicin—hematologic cancer	1.87e-06	4.3e-05	CcSEcCtD
Nelarabine—Dizziness—Doxorubicin—hematologic cancer	1.83e-06	4.2e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—TP53—hematologic cancer	1.78e-06	8.65e-05	CbGpPWpGaD
Nelarabine—Nausea—Epirubicin—hematologic cancer	1.78e-06	4.08e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—PIK3CB—hematologic cancer	1.77e-06	8.61e-05	CbGpPWpGaD
Nelarabine—Vomiting—Doxorubicin—hematologic cancer	1.76e-06	4.04e-05	CcSEcCtD
Nelarabine—Headache—Doxorubicin—hematologic cancer	1.73e-06	3.98e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—PTEN—hematologic cancer	1.66e-06	8.07e-05	CbGpPWpGaD
Nelarabine—Nausea—Doxorubicin—hematologic cancer	1.64e-06	3.78e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—EP300—hematologic cancer	1.58e-06	7.69e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—hematologic cancer	1.53e-06	7.44e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—EP300—hematologic cancer	1.46e-06	7.1e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—hematologic cancer	1.17e-06	5.69e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—hematologic cancer	1.08e-06	5.25e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—hematologic cancer	9.58e-07	4.65e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—hematologic cancer	8.84e-07	4.29e-05	CbGpPWpGaD
